Evangelopoulos Dimitrios-Stergios

Dr. Evangelopoulos Dimitrios-Stergios

MD, Drmed, MSc, PhD: Academic Fellow, 3rd Department of Orhopaedic Surgery, University of Athens, KAT Hospital, Athens Greece

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in The Knee
Verified
Journal Article
Closed access
SKSandro Kohl
Sandro Kohl
CSChantal Stutz
Chantal Stutz
SDSebastian Decker
Sebastian Decker
KZKai Ziebarth
Kai Ziebarth
TSTheddy Slongo
Theddy Slongo
EDEvangelopoulos Dimitrios-Stergios
Evangelopoulos Dimitrios-Stergios

2 February 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Elias VasiliadisElias Vasiliadis
Elias Vasiliadis
EDEvangelopoulos Dimitrios-Stergios
Evangelopoulos Dimitrios-Stergios
AKAngelos Kaspiris
Angelos Kaspiris
IBIoannis Benetos
Ioannis Benetos
CVChristos Vlachos
Christos Vlachos
SPSpyros G. Pneumaticos
Spyros G. Pneumaticos
Sclerostin has been identified as an important regulator of bone homeostasis through inhibition of the canonical Wnt-signaling pathway, and it is involved in the pathogenesis of many different skeletal diseases. Many studies have been published in the last few years regarding sclerostin’s origin, regulation, and mechanism of action. The ongoing research emphasizes the potential therapeutic implications of sclerostin in many pathological conditions with or without skeletal involvement. Antisclerostin antibodies have recently been approved for the treatment of osteoporosis, and several animal studies and clinical trials are currently under way to evaluate the effectiveness of antisclerostin antibodies in the treatment of other than osteoporosis skeletal disorders and cancer with promising results. Understanding the exact role of sclerostin may lead to new therapeutic approaches for the treatment of skeletal disorders.

14 July 2011 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
GBGeorge C Babis
George C Babis
EDEvangelopoulos Dimitrios-Stergios
Evangelopoulos Dimitrios-Stergios
PKPanagiotis Kontovazenitis
Panagiotis Kontovazenitis
KNKonstantinos Nikolopoulos
Konstantinos Nikolopoulos
PSPanagiotis N Soucacos
Panagiotis N Soucacos
Management of high energy intra-articular fractures of the proximal tibia, associated with marked soft-tissue trauma, can be challenging, requiring the combination of accurate reduction and minimal invasive techniques. The purpose of this study was to evaluate whether minimal intervention and hybrid external fixation of such fractures using the Orthofix system provide an acceptable treatment outcome with less complications. Between 2002 and 2006, 33 patients with a median ISS of 14.3 were admitted to our hospital, a level I trauma centre, with a bicondylar tibial plateau fracture. Five of them sustained an open fracture. All patients were treated with a hybrid external fixator. In 19 of them, minimal open reduction and stabilization, by means of cannulated screws, was performed. Mean follow-up was 27 months (range 24 to 36 months). Radiographic evidence of union was observed at 3.4 months (range 3 to 7 months). Time for union was different in patients with closed and grade I open fractures compared to patients with grade II and III open fractures. One non-union (septic) was observed (3.0%), requiring revision surgery. Pin track infection was observed in 3 patients (9.1%).Compared to previously reported series of conventional open reduction and internal fixation, hybrid external fixation with or without open reduction and minimal internal fixation with the Orthofix system, was associated with satisfactory clinical and radiographic results and limited complications.

1 June 2016 in The Knee
Verified
Journal Article
Closed access
LBLorenz Büchler
Lorenz Büchler
DRDorina Regli
Dorina Regli
EDEvangelopoulos Dimitrios-Stergios
Evangelopoulos Dimitrios-Stergios
KBKathrin Bieri
Kathrin Bieri
SASuhaib JS. Ahmad
Suhaib JS. Ahmad
SKSandro Kohl
Sandro Kohl

1 March 2014 in The Knee
Verified
Journal Article
Closed access
SKSandro Kohl
Sandro Kohl
EDEvangelopoulos Dimitrios-Stergios
Evangelopoulos Dimitrios-Stergios
SASuhaib JS. Ahmad
Suhaib JS. Ahmad
HKHeindrik Kohlhof
Heindrik Kohlhof
GHGudrun Herrmann
Gudrun Herrmann
SEStefan Eggli
Stefan Eggli

15 July 2022 in Cureus
Verified
Journal Article
Open access
GTGeorgios Tsalimas
Georgios Tsalimas
EDEvangelopoulos Dimitrios-Stergios
Evangelopoulos Dimitrios-Stergios
IBIoannis Benetos
Ioannis Benetos
SPSpiros Pneumaticos
Spiros Pneumaticos
Anterior cervical discectomy and fusion (ACDF), despite its possible complications, remains the gold standard for the surgical treatment of patients with radiculopathy and/or myelopathy caused by cervical intervertebral disc herniation or spondylosis. Despite its high rate of incidence, postoperative dysphagia following ACDF is still poorly understood; its pathogenesis remains relatively unknown, and its risk factors are still a subject of debate. The aim of this study is to review the incidence, pathogenesis, diagnosis, and methods of prevention of dysphagia in ACDF patients. To this end, a literature review was conducted based on the PubMed internet database. Article titles were searched by using the following keywords: “dysphagia” and “anterior cervical discectomy and fusion” or “ACDF”. The search was limited to prospective clinical studies evaluating dysphagia after ACDF surgery. Studies published in non-English languages, retrospective studies, cadaveric studies, reviews, case reports, study protocols, and commentary studies were excluded. Initially, 335 studies were identified after a primary search. After the application of the exclusion criteria, 73 studies remained for the final analysis. This literature review focused on identifying the rate of dysphagia and the various risk factors leading to this complication by comparing and evaluating the current literature with a wide spectrum of heterogeneity concerning patients, surgeons, and surgical techniques. A mean dysphagia rate of 19.4% (95% CI: 9.6%-29.1%) based on the findings of the included studies correlating dysphagia directly with ACDF procedures was calculated. Various established risk factors leading to dysphagia include the female sex, smoking, the surgical approach, rhBMP-2 use, and multilevel surgery, while zero-profile devices seem to reduce dysphagia risk. The diagnosis is based on clinical and radiological findings, especially prevertebral soft-tissue swelling. However, videofluoroscopic and endoscopic studies have been recently used for the evaluation of dysphagia. The role of local administration of steroids in the prevention of dysphagia has not yet been clarified. This review underscores the prevailing rudimentary understanding of the problem of dysphagia after ACDF procedures and highlights the need for more sensitive, factor-specific studies for understanding the impact of various risk factors on the incidence rate of dysphagia.